相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients
Jean Jacques Noubiap et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2022)
Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis
Yi-Xing Yang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease
Dharam J. Kumbhani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction
Patricia O. Guimaraes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Temporal trends and outcomes associated with atrial fibrillation observed during acute coronary syndrome: Real-world data from the Acute Coronary Syndrome Israeli Survey (ACSIS), 2000-2013
Aharon Erez et al.
CLINICAL CARDIOLOGY (2017)
Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation
Lluis Pujadas-Mestres et al.
PLOS ONE (2017)
Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries
Andreea D. Ceornodolea et al.
STROKE RESEARCH AND TREATMENT (2017)
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
Renato D. Lopes et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
Martin J. O'Donnell et al.
LANCET (2016)
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding
Pasquale Pignatelli et al.
PHARMACOLOGICAL RESEARCH (2016)
The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis
Wengen Zhu et al.
CLINICAL CARDIOLOGY (2015)
Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation
Hector Gonzalez-Pacheco et al.
JOURNAL OF CARDIOLOGY (2015)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL (2014)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Unrecognized myocardial infarction and risk of atrial fibrillation: The Rotterdam Study
Bouwe P. Krijthe et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?
Nadine E. Andrew et al.
NEUROEPIDEMIOLOGY (2013)
Trends in Atrial Fibrillation in Patients Hospitalized with an Acute Coronary Syndrome
David D. McManus et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa
Mohammad Al-Tamimi et al.
BLOOD (2011)
Incidence and Severity of Coronary Artery Disease in Patients with Atrial Fibrillation Undergoing First-Time Coronary Angiography
Stefan Kralev et al.
PLOS ONE (2011)
LESS IS MORE Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
Morten L. Hansen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Signaling During Platelet Adhesion and Activation
Zhenyu Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Nirmala Raghavan et al.
DRUG METABOLISM AND DISPOSITION (2009)
P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
Lars Wallentin
EUROPEAN HEART JOURNAL (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
Shinya Goto et al.
AMERICAN HEART JOURNAL (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
Anetta Undas et al.
BLOOD (2007)
Atrial fibrillation is associated with severe acute ischemic stroke
DA Dulli et al.
NEUROEPIDEMIOLOGY (2003)
Oral anticoagulants in patients with coronary artery disease
SS Anand et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation - An individual patient meta-analysis
C van Walraven et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
